Formulations and methods for treating dry eye

Details for Australian Patent Application No. 2008262491 (hide)

Owner Aciex Therapeutics, Inc.

Inventors Ousler III, George W.; Chapin, Matthew Jonathan; Abelson, Mark B.

Agent Cullens

Pub. Number AU-A-2008262491

PCT Pub. Number WO2008/153746

Priority 61/066,153 18.06.07 US; 61/124,804 02.08.07 US; 61/124,800 24.05.07 US

Filing date 23 May 2008

Wipo publication date 18 December 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/153746 Priority application(s): WO2008/153746

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262495-Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

2008262490-Compositions and methods for producing bioactive fusion proteins